| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10,6 M € | — | — | — | — | 10,1 M € | +18.0% | 8,6 M € | +85.6% | 4,6 M € | — | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||
| Gross margin | — | 4,6 M € | +33.3% | 3,5 M € | +19.9% | 2,9 M € | -6.7% | 3,1 M € | — | — | — | 2,6 M € | +5.2% | 2,5 M € | +15.9% | 2,1 M € | +4.3% | 2,0 M € | -0.1% | 2,0 M € | -1.2% | 2,1 M € | -12.0% | 2,3 M € | +6.2% | 2,2 M € | -14.9% | 2,6 M € | +0.0% | 2,6 M € | +37.0% | 1,9 M € | ||||||
| EBITDA | 683,1 k € | -57.2% | 1,6 M € | +111.0% | 756,3 k € | +74.8% | 432,6 k € | +20.0% | 360,5 k € | -47.0% | 680,0 k € | +26.2% | 538,8 k € | +31.3% | 410,3 k € | -43.0% | 719,3 k € | +27.8% | 562,8 k € | +12.4% | 500,6 k € | -7.9% | 543,4 k € | +32.2% | 411,0 k € | -27.8% | 569,7 k € | -42.0% | 981,8 k € | +3.0% | 953,4 k € | -32.9% | 1,4 M € | -15.9% | 1,7 M € | +20.9% | 1,4 M € | |
| Operating profit | 548,0 k € | -58.1% | 1,3 M € | +123.4% | 585,1 k € | +374.6% | 123,3 k € | +782.5% | -18,1 k € | -116.6% | 108,7 k € | +190.3% | -120,5 k € | -476.7% | -20,9 k € | -119.1% | 109,3 k € | -22.3% | 140,7 k € | +24.7% | 112,9 k € | -44.7% | 204,1 k € | +2.8% | 198,5 k € | +36.0% | 146,0 k € | -74.4% | 570,9 k € | -1.7% | 580,6 k € | -45.2% | 1,1 M € | -21.6% | 1,4 M € | +29.7% | 1,0 M € | |
| Profit/loss | 291,3 k € | -68.2% | 915,5 k € | +116.7% | 422,5 k € | +366.3% | 90,6 k € | -14.2% | 105,6 k € | -58.5% | 254,3 k € | +53.8% | 165,3 k € | +2.4% | 161,5 k € | -46.2% | 300,1 k € | +20.8% | 248,5 k € | +36.7% | 181,7 k € | -33.0% | 271,2 k € | +77.1% | 153,1 k € | +45.8% | 105,0 k € | -73.5% | 396,0 k € | +9.7% | 361,2 k € | -51.9% | 750,7 k € | -16.0% | 893,3 k € | +38.3% | 646,1 k € | |
| Equity | 3,1 M € | +9.0% | 2,8 M € | +47.0% | 1,9 M € | +24.9% | 1,5 M € | +3.0% | 1,5 M € | -5.1% | 1,6 M € | -54.8% | 3,5 M € | +5.7% | 3,3 M € | +7.8% | 3,0 M € | +12.4% | 2,7 M € | +9.6% | 2,5 M € | +6.3% | 2,3 M € | +10.8% | 2,1 M € | -7.2% | 2,3 M € | +1.0% | 2,2 M € | +7.9% | 2,1 M € | +7.3% | 1,9 M € | +41.9% | 1,4 M € | +44.0% | 942,9 k € | |
| Total assets | 8,5 M € | +35.1% | 6,3 M € | +20.9% | 5,2 M € | +24.4% | 4,2 M € | -3.3% | 4,3 M € | -23.8% | 5,7 M € | -26.1% | 7,7 M € | +2.6% | 7,5 M € | +26.1% | 6,0 M € | +15.4% | 5,2 M € | -0.9% | 5,2 M € | -1.7% | 5,3 M € | +7.3% | 4,9 M € | -3.7% | 5,1 M € | -0.6% | 5,2 M € | -1.7% | 5,3 M € | -2.4% | 5,4 M € | +3.7% | 5,2 M € | -5.3% | 5,5 M € | |
| Cash | 63,1 k € | -90.0% | 631,5 k € | +159.2% | 243,6 k € | -55.7% | 550,0 k € | +158.3% | 212,9 k € | -43.9% | 379,8 k € | +109.3% | 181,4 k € | -21.4% | 230,9 k € | +122.3% | 103,9 k € | -24.9% | 138,3 k € | +34.9% | 102,6 k € | -27.9% | 142,2 k € | -40.9% | 240,7 k € | +0.0% | 240,7 k € | +22.3% | 196,9 k € | +23.5% | 159,4 k € | +111.0% | 75,6 k € | -55.9% | 171,2 k € | -69.8% | 566,2 k € | |
| Debts | 5,5 M € | +56.3% | 3,5 M € | +10.0% | 3,2 M € | +20.5% | 2,6 M € | -6.5% | 2,8 M € | -31.6% | 4,1 M € | +0.4% | 4,1 M € | -0.7% | 4,1 M € | +44.6% | 2,9 M € | +19.6% | 2,4 M € | -10.4% | 2,7 M € | -5.7% | 2,8 M € | +5.1% | 2,7 M € | -2.3% | 2,7 M € | -0.5% | 2,8 M € | -7.3% | 3,0 M € | -6.7% | 3,2 M € | -14.4% | 3,7 M € | -17.3% | 4,5 M € | |
| Staff | 52,4 | 51,8 | 54,4 | 55,3 | 57,6 | 60,2 | 47 | 43,8 | 41,9 | 45,2 | 39,5 | 34,8 | 38,1 | 39,1 | 35,4 | 33 | 31,6 | 28,2 | 12,3 | |||||||||||||||||||
Public limited company · Liège · incorporated on 18/02/1994 · 52,4 ETP
Public limited company profitable and well capitalised. Cash position declining (-90.0%).
Solid counterparty for a standard engagement.
MEDI - LINE is a Public limited company incorporated in 1994. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Liège. It employs on average 52,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette